You have 9 free searches left this month | for more free features.

Infliximab

Showing 26 - 50 of 774

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Trial in Jena (Infliximab, Standard of Care)

Recruiting
  • COVID-19
  • Infliximab
  • Standard of Care
  • Jena, Germany
    Jena University Hospital
Aug 10, 2022

A Cohort Study Comparing IFX to CS for Moderate to Severe UC

Recruiting
  • Moderate to Severe Ulcerative Colitis
  • Guandong, China
    The Sixth Affiliated Hospital, Sun Yat-sen University
Nov 22, 2022

Glaucoma Following Surgery Trial in Montréal (Topical infliximab, No topical infliximab)

Recruiting
  • Glaucoma Following Surgery
  • Topical infliximab
  • No topical infliximab
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Jul 4, 2022

Ulcerative Colitis Trial in Melbourne (Infliximab)

Active, not recruiting
  • Ulcerative Colitis
  • Infliximab
  • Melbourne, Victoria, Australia
    Austin Health
Jun 19, 2022

Exclusive Enteral Nutrition, Ulcerative Colitis, Children Trial (exclusive enteral nutrition, regular food)

Not yet recruiting
  • Exclusive Enteral Nutrition
  • +2 more
  • exclusive enteral nutrition
  • regular food
  • (no location specified)
Dec 5, 2022

Crohn Disease Trial in United States (RoadMAB, Infliximab)

Not yet recruiting
  • Crohn Disease
  • RoadMAB
  • Infliximab
  • Los Angeles, California
  • +9 more
Dec 19, 2022

Tocilizumab Versus Tocilizumab/Infliximab in COVID-19-associated

Completed
  • Covid19
  • +2 more
  • Cairo, Please Select, Egypt
    Teachers Hospital
Jul 19, 2022

Crohn's Disease Trial in Warszawa (CT-P13 SC (Infliximab), Placebo SC)

Active, not recruiting
  • Crohn's Disease
  • CT-P13 SC (Infliximab)
  • Placebo SC
  • Warszawa, Poland
    WIP Warsaw IBD Point Profesor Kierkus
Dec 6, 2022

Aneurysm, Stroke, Vasculitis Trial in San Francisco (Infliximab)

Enrolling by invitation
  • Aneurysm
  • +3 more
  • Infliximab
  • San Francisco, California
    UCSF Medical Center
Apr 25, 2022

Schizophrenia Trial in Atlanta (Infliximab, Placebo)

Not yet recruiting
  • Schizophrenia
  • Infliximab
  • Placebo
  • Atlanta, Georgia
  • +1 more
Apr 10, 2023

Biomarkers to Predict and Monitor Response to Infliximab

Recruiting
  • Crohn Disease
  • Infliximab
  • Boston, Massachusetts
    MassGeneral for Children
Apr 5, 2022

Depression Trial in Atlanta (Infliximab, Placebo)

Active, not recruiting
  • Depression
  • Infliximab
  • Placebo
  • Atlanta, Georgia
    Emory University
Jan 23, 2023

Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease

Not yet recruiting
  • Rheumatoid Arthritis
  • +2 more
  • collection of clinical parameters and blood sample
  • Paris, IDF, France
    Rheumatology Department, Cochin Hospital
Jun 17, 2022

IBD Trial in Leuven (Infliximab)

Recruiting
  • Inflammatory Bowel Diseases
  • Infliximab
  • Leuven, Vlaanderen, Belgium
    UZ Leuven
Feb 11, 2022

Metastatic Melanoma Trial in Boston (Pembrolizumab, Infliximab, Placebo)

Recruiting
  • Metastatic Melanoma
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Apr 6, 2022

Irritable Bowel Disease Trial in Cairo (Infliximab, Adalimumab)

Recruiting
  • Irritable Bowel Disease
  • Cairo, Egypt
    Tropical Medicine department, Ain Shams University Hospitals.
Mar 12, 2022

Fate in Fistulizing Crohn's Disease in a Pediatric Population

Active, not recruiting
  • Crohn Disease
  • Infliximab
  • Stomy
  • (no location specified)
Feb 25, 2023

Colitis, Ulcerative Trial in Amsterdam (Infliximab)

Recruiting
  • Colitis, Ulcerative
  • Infliximab
  • Dublin, Ireland
  • +6 more
Dec 2, 2022

Ulcerative Colitis Trial (Appendectomy, Infliximab)

Not yet recruiting
  • Ulcerative Colitis
  • Appendectomy
  • Infliximab
  • (no location specified)
Jun 27, 2023

IBD Trial in Trieste (Infliximab)

Recruiting
  • Inflammatory Bowel Diseases
  • Infliximab
  • Trieste, Italy
    Institute for Maternal and Child Health - IRCCS "Burlo Garofolo"
Mar 18, 2022

Melanoma Trial in Toulouse (Nivolumab+Ipilimumab in combination with Anti TNF-a Certolizumab, Nivolumab+Ipilimumab in

Active, not recruiting
  • Melanoma
  • Nivolumab+Ipilimumab in combination with Anti TNF-α Certolizumab
  • Nivolumab+Ipilimumab in combination with Anti TNF-α Infliximab
  • Toulouse, France
    Institut Claudius Regaud IUCT-ONCOPOLE
Nov 18, 2022

Crohn Disease Trial (Azathioprine + infliximab, Intestinal resection)

Not yet recruiting
  • Crohn Disease
  • Azathioprine + infliximab
  • Intestinal resection
  • (no location specified)
Oct 14, 2022

Ulcerative Colitis, Infliximab, Children Trial in Shanghai (Infliximab, Corticosteroids)

Recruiting
  • Ulcerative Colitis
  • +2 more
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
Feb 5, 2022

Uveitis, Infliximab Trial (infliximab)

Active, not recruiting
  • Uveitis
  • Infliximab
  • infliximab
  • (no location specified)
Oct 28, 2021

Pediatric HSCT Recipients With aGVHD: Prospective Observational

Recruiting
  • Graft Versus Host Disease, Acute
  • Hematopoietic Stem Cell Transplantation
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Apr 30, 2022